Skip to main content
Premium Trial:

Request an Annual Quote

Pyrosequencing Reports Increase in Q1 Revenues

 NEW YORK, April 24 - Pyrosequencing of Uppsala, Sweden reported a 21 percent increase in first-quarter revenues today, amid slightly narrowed losses.


The company's revenues for the quarter ended March 31 totaled 24.2 million Swedish Kronor ($2.9 million), compared to 20.0 million Kronor ($2.4 million) for the first quarter of last year.  The company said its revenues would have increased further, excluding currency effects.


Pyrosequencing's net losses totaled 30.0 million Kronor ($3.6 million) compared to 32.2 million ($3.9 million) for the first quarter of last year.


As of March 31, Pyrosequencing had 136.7 million Kronor in cash and short-term investments, compared to 97.3 million at the end of 2002. The increase came from a shift to cash and short-term investments of other marketable securities - which totaled 292.3 million Kronor at the end of March, and 374.4 million Kronor at the end of December.

The Scan

Ancient Greek Army Ancestry Highlights Mercenary Role in Historical Migrations

By profiling genomic patterns in 5th century samples from in and around Himera, researchers saw diverse ancestry in Greek army representatives in the region, as they report in PNAS.

Estonian Biobank Team Digs into Results Return Strategies, Experiences

Researchers in the European Journal of Human Genetics outline a procedure developed for individual return of results for the population biobank, along with participant experiences conveyed in survey data.

Rare Recessive Disease Insights Found in Individual Genomes

Researchers predict in Genome Medicine cross-population deletions and autosomal recessive disease impacts by analyzing recurrent nonallelic homologous recombination-related deletions.

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.